The Founder's Guide to

Curie Capital BV

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Founded in 2018 and based in Amsterdam, Curie Capital BV is a venture capital firm dedicated to the Life Sciences sector. The firm manages investments primarily in early-stage companies, particularly in biotechnology, pharmaceuticals, and medical technology. Curie Capital adheres to RVO seed capital regulations, investing in companies that have not raised more than €3.5 million in equity or convertible loans.

Learn More

Frequently Asked Questions

Does Curie Capital lead rounds?

Yes, Curie Capital often leads investment rounds in the companies they back, particularly in the Seed and Series A stages.

What is Curie Capital's stance on follow-on investments?

Curie Capital is open to follow-on investments, especially if the portfolio company demonstrates significant growth potential and aligns with their investment thesis.

How large is Curie Capital's current fund?

Specific fund size details are not disclosed, but Curie Capital focuses on early-stage investments within the constraints of RVO regulations.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.